Aicher S A, Sharma S, Pickel V M
Department of Neurology and Neuroscience, Cornell University Medical College, New York, NY 10021, USA.
Neuroscience. 1999;91(1):119-32. doi: 10.1016/s0306-4522(98)00530-2.
N-Methyl-D-aspartate receptors are present in the nodose ganglion, which contains the cell bodies of vagal afferents, and in the nucleus tractus solitarius, where these afferent fibers terminate. This suggests that N-methyl-D-aspartate receptors are located presynaptically on visceral vagal afferents and/or their target neurons in the nucleus tractus solitarius. To test this hypothesis, we combined anterograde transport of biotinylated dextran amine, following injections into the left nodose ganglion, with electron microscopic immunogold labeling of antipeptide antiserum against the R1 subunit of the N-methyl-D-aspartate receptor in the nucleus tractus solitarius of rat brain. Within the medial nucleus tractus solitarius, the N-methyl-D-aspartate receptor R1 immunoreactivity was seen in dendrites (39% of 639 profiles), axons and axon terminals (41%), and a few neuronal perikarya and glia. Many vagal afferent axons and terminals (40% of 468 profiles) contained N-methyl-D-aspartate receptor R1 immunogold labeling. In addition, 42% of the dendrites contacted by vagal afferent terminals (n = 206) contained N-methyl-D-aspartate receptor R1 immunoreactivity. In axons and dendrites, the gold particles were occasionally seen within asymmetric postsynaptic junctions or at non-synaptic sites on the plasma membrane. More commonly, however, N-methyl-D-aspartate receptor R1 labeling was seen on membranes of vesicular cytoplasmic organelles, suggesting that there is abundant N-methyl-D-aspartate receptor protein available for activity-dependent mobilization to the plasmalemma. Since many vagal afferents are glutamatergic, our results implicate N-methyl-D-aspartate receptors in autoregulation of the presynaptic release and postsynaptic responses to glutamate at the level of the first central synapse in the nucleus tractus solitarius.
N-甲基-D-天冬氨酸受体存在于含有迷走神经传入纤维细胞体的结状神经节以及这些传入纤维终末所在的孤束核中。这表明N-甲基-D-天冬氨酸受体位于迷走神经内脏传入纤维的突触前以及/或者孤束核中的靶神经元上。为了验证这一假说,我们将向左侧结状神经节注射生物素化葡聚糖胺后的顺行运输与大鼠脑孤束核中针对N-甲基-D-天冬氨酸受体R1亚基的抗肽抗血清的电子显微镜免疫金标记相结合。在孤束核内侧,N-甲基-D-天冬氨酸受体R1免疫反应性见于树突(639个轮廓中的39%)、轴突和轴突终末(41%),以及少数神经元胞体和神经胶质细胞。许多迷走神经传入轴突和终末(468个轮廓中的40%)含有N-甲基-D-天冬氨酸受体R1免疫金标记。此外,与迷走神经传入终末接触的树突中有42%(n = 206)含有N-甲基-D-天冬氨酸受体R1免疫反应性。在轴突和树突中,金颗粒偶尔见于不对称突触后连接内或质膜上的非突触部位。然而,更常见的是,在囊泡状细胞质细胞器的膜上可见N-甲基-D-天冬氨酸受体R1标记,这表明有大量的N-甲基-D-天冬氨酸受体蛋白可用于依赖活性的向质膜的转运。由于许多迷走神经传入纤维是谷氨酸能的,我们的结果表明N-甲基-D-天冬氨酸受体在孤束核中第一个中枢突触水平对谷氨酸的突触前释放和突触后反应的自动调节中起作用。